Rare cutaneous lupus erythematosus
- Type
- Clinical group
- Group
- Group of disorders
- Inheritance
- Multigenic/multifactorial
- Age of onset
- All ages
- Status
- active
Rare cutaneous lupus erythematosus (CLE) is an autoimmune disease that denotes a heterogeneous spectrum of clinical manifestations affecting the skin and can be divided into 4 categories: acute CLE (ACLE); subacute CLE (SCLE); chronic CLE (CCLE; the most diverse form); and intermittent CLE (ICLE). CLE can either occur alone or associated with systemic lupus erythematosus (SLE).
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Rare cutaneous lupus erythematosus | |
| fr | Lupus érythémateux cutané rare | |
| de | Lupus erythematodes, kutaner seltener | |
| es | Lupus eritematoso cutáneo raro | |
| it | Lupus eritematoso cutaneo | |
| nl | Zeldzame cutane lupus erythematosus | |
| pt | Lúpus eritematoso cutâneo raro | |
| pl | Rzadka postać tocznia rumieniowatego skórnego | |
| cs | Kožní lupus erythematodes | |
| uk | Рідкісний шкірний червоний вовчак | |
| zh | 罕见皮肤红斑狼疮 | |
| tr | Nadir kutanöz lupus eritematozus |
Definition in:
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| MONDO | 18887 | E | validated | |
| UMLS | C5680424 | E | validated | |
| GARD | 6225 | E | validated | |
| MedDRA | 10056509 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:315350Autoimmune disease with skin involvement
rare skin diseases
Codes that Orphanet moved or referred to this one:
- ORPHA:46489OBSOLETE: Bullous systemic lupus erythematosus referred to · inactive
- ORPHA:90287OBSOLETE: Maculopapular lupus rash referred to · inactive
- ORPHA:163528OBSOLETE: Acute cutaneous lupus erythematosus referred to · inactive
Genes
0 directOrphanet records no gene directly on this code.
Prevalence and incidence
4 records| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Point prevalence | 1-5 / 10 000 | 50 / 100 000 | Europe | Value and class | Validated | European Medicines Agency 2007[OTHER] |
| Annual incidence | 1-9 / 100 000 | 4.3 / 100 000 | United States | Value and class | Validated | 19289752[PMID] |
| Point prevalence | 6-9 / 10 000 | 73 / 100 000 | United States | Value and class | Validated | 19289752[PMID] |
| Annual incidence | 1-9 / 100 000 | 4 / 100 000 | Sweden | Value and class | Validated | 21574972[PMID] |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
HPO phenotypes
Orphanet has no HPO annotation for this code in this release.
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/535
- This record as JSON: /data/d/535.json